Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Tumor Vs Normal Gene Expression Profiles Identify Deregulated Pathways in ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia: A Microarray-Based Meta-Analysis

Thomas Heiden, PhD, Janette Nickel, Robert Preissner, PhD, Karl Seeger, Prof. PhD

Blood (2015) 126 (23): 4812.

https://doi.org/10.1182/blood.V126.23.4812.4812

Published: 2015

Journal Articles

Genome-Wide Mapping of Binding Sites and Networks of Potential Target Genes of the Fusion Oncogene ETV6/RUNX1 in Acute Lymphoblastic Leukemia in Childhood

Katja Kaulfuss, Thomas Heiden, PhD, Jochen Hecht, Karl Seeger

Blood (2014) 124 (21): 3776.

https://doi.org/10.1182/blood.V124.21.3776.3776

Published: 2014

Journal Articles

A novel flow cytometry–based platelet aggregation assay

Iris M. De Cuyper, Marjolein Meinders, Edith van de Vijver, Dirk de Korte, Leendert Porcelijn, Masja de Haas, Johannes A. Eble, Karl Seeger, Sergio Rutella, Daria Pagliara, Taco W. Kuijpers, Arthur J. Verhoeven, Timo K. van den Berg, Laura Gutiérrez

Blood (2013) 121 (10): e70–e80.

https://doi.org/10.1182/blood-2012-06-437723

Published: 2013

Includes: Supplemental data

Journal Articles

Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin β1 and β3 in platelet adhesion to collagen

Edith van de Vijver, Iris M. De Cuyper, Anja J. Gerrits, Arthur J. Verhoeven, Karl Seeger, Laura Gutiérrez, Timo K. van den Berg, Taco W. Kuijpers

Blood (2012) 119 (2): 583–586.

https://doi.org/10.1182/blood-2011-02-337188

Published: 2012

Journal Articles

LAD-1/variant syndrome is caused by mutations in FERMT3

Taco W. Kuijpers, Edith van de Vijver, Marian A. J. Weterman, Martin de Boer, Anton T. J. Tool, Timo K. van den Berg, Markus Moser, Marja E. Jakobs, Karl Seeger, Özden Sanal, Sule Ünal, Mualla Çetin, Dirk Roos, Arthur J. Verhoeven, Frank Baas

Blood (2009) 113 (19): 4740–4746.

https://doi.org/10.1182/blood-2008-10-182154

Published: 2009

Journal Articles

Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002

Cornelia Eckert, PhD, Arend Stackelberg, MD, Nikola Hagedorn, Andrea Barth, Karl Seeger, MD, PhD, Guenter Henze, MD

Blood (2008) 112 (11): 2515.

https://doi.org/10.1182/blood.V112.11.2515.2515

Published: 2008

Journal Articles

Genomic Profiling helps to Predict Treatment Response and Outcome in Relapsed Childhood ETV6/RUNX1 -Positive Acute Lymphoblastic Leukemia.

Almut Giese, Reinhard Ullmann, PhD, Cornelia Eckert, PhD, Renate Kirschner-Schwabe, PhD, Guenter Henze, MD, Karl Seeger, MD, PhD

Blood (2008) 112 (11): 1485.

https://doi.org/10.1182/blood.V112.11.1485.1485

Published: 2008

Journal Articles

Histone Deacetylase Inhibition Improves Differentiation of Dendritic Cells from Leukemic Blasts of Patients with TEL/AML1-Positive Acute Lymphoblastic Leukemia

Kerstin Schmidt, MSc, Karl Seeger, MD, PhD, Carmen Scheibenbogen, Roderich Bender, MD, Sina Süßmilch, Abdulgabar Salama, Anja Moldenhauer, MD

Blood (2008) 112 (11): 3952.

https://doi.org/10.1182/blood.V112.11.3952.3952

Published: 2008

Journal Articles

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert

Blood (2007) 110 (12): 4022–4029.

https://doi.org/10.1182/blood-2007-04-082040

Published: 2007

Includes: Supplemental data

Journal Articles

Histone Deacetylase Inhibitors as Adjuvants for the Differentiation of Dendritic Cell from Leukemic Blasts.

Anja Moldenhauer, MD, Karl Seeger, MD, PhD, Kerstin Schmidt, Holger Kiesewetter, Abdulgabar Salama

Blood (2007) 110 (11): 4341.

https://doi.org/10.1182/blood.V110.11.4341.4341

Published: 2007

Journal Articles

Natural history and early diagnosis of LAD-1/variant syndrome

Taco W. Kuijpers, Robin van Bruggen, Nanne Kamerbeek, Anton T. J. Tool, Gonul Hicsonmez, Aytemiz Gurgey, Axel Karow, Arthur J. Verhoeven, Karl Seeger, Özden Sanal, Charlotte Niemeyer, Dirk Roos

Blood (2006) 109 (8): 3529–3537.

https://doi.org/10.1182/blood-2006-05-021402

Published: 2006

Includes: Multimedia, Supplemental data

Journal Articles

Glucocorticoid Therapy Targets Proliferation, Differentiation and Bcl-2 Dependent Survival Signaling in ALL Blasts.

Peter Rhein, Stefanie Scheid, Richard Ratei, MD, Christian Hagemeier, PhD, MD, Karl Seeger, PhD, MD, Renate Kirschner-Schwabe, PhD, Martin Schrappe, MD, Rainer Spang, PhD, Wolf-Dieter Ludwig, MD, Leonid Karawajew, PhD

Blood (2006) 108 (11): 1841.

https://doi.org/10.1182/blood.V108.11.1841.1841

Published: 2006

Journal Articles

BCR-ABL Specific Sequences Are Required To Prevent Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice by DNA Vaccination.

Joachim Köchling, Javier Prada, Masoud Bahrami, Sven A. König Merediz, Renata Stripecke, Karl Seeger, Günter Henze, Burghardt Wittig, Manuel Schmidt

Blood (2006) 108 (11): 3262.

https://doi.org/10.1182/blood.V108.11.3262.3262

Published: 2006

Journal Articles

TEL/AML1 Expression in a Non-B Cell Line Induces a Set of Differentially Expressed Genes, but Points to Cell Type Specific Effects of the Fusion Protein in Leukemic Blasts of TEL/AML1 Positive Patients.

Kerstin Hasse, Renate Kirschner-Schwabe, Claudio Lottaz, Jutta Proba, Ute Ungetuem, Rainer Spang, Guenter Henze, Dr., Karl Seeger, PD, Dr.

Blood (2006) 108 (11): 2221.

https://doi.org/10.1182/blood.V108.11.2221.2221

Published: 2006

Journal Articles

Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts.

Georg Seifert, Holger N. Lode, MD, Stephan Lobitz, MD, Karl Seeger, MD, PhD, Alfred Laengler, MD, Guenter Henze, MD

Blood (2005) 106 (11): 3919.

https://doi.org/10.1182/blood.V106.11.3919.3919

Published: 2005

Journal Articles

The Expression of LI-Cadherin in Bone Marrow Is Correlated with Clinical Outcome in Children with Acute Lymphoblastic Leukemia at First Relapse.

Shuling Wu, MD, Anay Marquetti Hernández, MD, Corinna Dietel, PhD, Arend von Stackelberg, MD, Guenter Henze, MD, Karl Seeger, MD, PhD, Reinhard Gessner, MD, PhD

Blood (2005) 106 (11): 1456.

https://doi.org/10.1182/blood.V106.11.1456.1456

Published: 2005

Journal Articles

Gene Expression in Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL Displays a Common Shift towards Terminally Differentiated B Cells and a Cytoreduction-Associated Impairment of the Translational Machinery.

Blood (2005) 106 (11): 537.

https://doi.org/10.1182/blood.V106.11.537.537

Published: 2005

Journal Articles

CD30 + Lymphoproliferative Disorder/Lymphomatoid Papulosis - A Regression Caused by Mistletoe Therapy.

Georg Seifert, Christoph Tautz, MD, Karl Seeger, MD, PhD, Guenter Henze, MD, Alfred Laengler, MD

Blood (2005) 106 (11): 4779.

https://doi.org/10.1182/blood.V106.11.4779.4779

Published: 2005

Journal Articles

Gene Expression Analysis of Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL.

Peter Rhein, Richard Ratei, Stefanie Scheid, Christian Hagemeier, Karl Seeger, Renate Kirschner, Martin Schrappe, Rainer Spang, Wolf-Dieter Ludwig, Leonid Karawajew

Blood (2004) 104 (11): 522.

https://doi.org/10.1182/blood.V104.11.522.522

Published: 2004

Journal Articles

Imatinib Mesylate (STI571) Considerably Affects Normal Human Bone Marrow Stromal Cell Growth in Vitro.

Daniela Melzer, MD, Ulf Neumann, MD, Wolfram Ebell, MD, Karl Seeger, MD, PhD, Peter Neuhaus, MD, Gerhard Gaedicke, MD, Tim H. Brummendorf, MD, Stefan Scheding, MD

Blood (2004) 104 (11): 2330.

https://doi.org/10.1182/blood.V104.11.2330.2330

Published: 2004

NARROW

Tumor Vs Normal Gene Expression Profiles Identify Deregulated Pathways in ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia: A Microarray-Based Meta-Analysis

Genome-Wide Mapping of Binding Sites and Networks of Potential Target Genes of the Fusion Oncogene ETV6/RUNX1 in Acute Lymphoblastic Leukemia in Childhood

A novel flow cytometry–based platelet aggregation assay

Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin β1 and β3 in platelet adhesion to collagen

LAD-1/variant syndrome is caused by mutations in FERMT3

Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002

Genomic Profiling helps to Predict Treatment Response and Outcome in Relapsed Childhood ETV6/RUNX1 -Positive Acute Lymphoblastic Leukemia.

Histone Deacetylase Inhibition Improves Differentiation of Dendritic Cells from Leukemic Blasts of Patients with TEL/AML1-Positive Acute Lymphoblastic Leukemia

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Histone Deacetylase Inhibitors as Adjuvants for the Differentiation of Dendritic Cell from Leukemic Blasts.

Natural history and early diagnosis of LAD-1/variant syndrome

Glucocorticoid Therapy Targets Proliferation, Differentiation and Bcl-2 Dependent Survival Signaling in ALL Blasts.

BCR-ABL Specific Sequences Are Required To Prevent Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice by DNA Vaccination.

TEL/AML1 Expression in a Non-B Cell Line Induces a Set of Differentially Expressed Genes, but Points to Cell Type Specific Effects of the Fusion Protein in Leukemic Blasts of TEL/AML1 Positive Patients.

Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts.

The Expression of LI-Cadherin in Bone Marrow Is Correlated with Clinical Outcome in Children with Acute Lymphoblastic Leukemia at First Relapse.

Gene Expression in Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL Displays a Common Shift towards Terminally Differentiated B Cells and a Cytoreduction-Associated Impairment of the Translational Machinery.

CD30 + Lymphoproliferative Disorder/Lymphomatoid Papulosis - A Regression Caused by Mistletoe Therapy.

Gene Expression Analysis of Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL.

Imatinib Mesylate (STI571) Considerably Affects Normal Human Bone Marrow Stromal Cell Growth in Vitro.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only